Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1976 1
1977 1
1992 13
1993 18
1994 151
1995 391
1996 411
1997 501
1998 432
1999 487
2000 490
2001 445
2002 432
2003 479
2004 453
2005 478
2006 533
2007 512
2008 494
2009 483
2010 436
2011 429
2012 417
2013 487
2014 393
2015 366
2016 346
2017 324
2018 323
2019 310
2020 286
2021 250
2022 170
2023 170
2024 91

Search Results

10,942 results

Results by year

Filters applied: . Clear all
Page 1
Dopamine partial agonists: a discrete class of antipsychotics.
Taylor D, Chithiramohan R, Grewal J, Gupta A, Hansen L, Reynolds GP, Pappa S. Taylor D, et al. Int J Psychiatry Clin Pract. 2023 Sep;27(3):272-284. doi: 10.1080/13651501.2022.2151473. Epub 2022 Dec 10. Int J Psychiatry Clin Pract. 2023. PMID: 36495086 Review.
Role of dopamine agonists in Parkinson's disease therapy.
Woitalla D, Buhmann C, Hilker-Roggendorf R, Höglinger G, Koschel J, Müller T, Weise D. Woitalla D, et al. J Neural Transm (Vienna). 2023 Jun;130(6):863-873. doi: 10.1007/s00702-023-02647-0. Epub 2023 May 11. J Neural Transm (Vienna). 2023. PMID: 37165120 Review.
Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease.
Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N, Duvvuri S, Gray DL, Huang X, Mailman RB. Lewis MM, et al. Biomolecules. 2023 May 12;13(5):829. doi: 10.3390/biom13050829. Biomolecules. 2023. PMID: 37238699 Free PMC article. Clinical Trial.
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
Pivonello C, Patalano R, Negri M, Pirchio R, Colao A, Pivonello R, Auriemma RS. Pivonello C, et al. Front Endocrinol (Lausanne). 2022 Jan 12;12:791633. doi: 10.3389/fendo.2021.791633. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35095761 Free PMC article. Review.
Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis.
Mendoza-Torreblanca JG, Cárdenas-Rodríguez N, Carro-Rodríguez J, Contreras-García IJ, Garciadiego-Cázares D, Ortega-Cuellar D, Martínez-López V, Alfaro-Rodríguez A, Evia-Ramírez AN, Ignacio-Mejía I, Vargas-Hernández MA, Bandala C. Mendoza-Torreblanca JG, et al. Int J Mol Sci. 2023 Jun 15;24(12):10199. doi: 10.3390/ijms241210199. Int J Mol Sci. 2023. PMID: 37373348 Free PMC article. Review.
Prolactinomas.
Wildemberg LE, Fialho C, Gadelha MR. Wildemberg LE, et al. Presse Med. 2021 Dec;50(4):104080. doi: 10.1016/j.lpm.2021.104080. Epub 2021 Oct 21. Presse Med. 2021. PMID: 34687915 Free article. Review.
Approach to the Patient With Prolactinoma.
Auriemma RS, Pirchio R, Pivonello C, Garifalos F, Colao A, Pivonello R. Auriemma RS, et al. J Clin Endocrinol Metab. 2023 Aug 18;108(9):2400-2423. doi: 10.1210/clinem/dgad174. J Clin Endocrinol Metab. 2023. PMID: 36974474 Free PMC article. Review.
10,942 results
You have reached the last available page of results. Please see the User Guide for more information.